Skip to main content

Articles Tagged With:

  • New Oral Contraceptive Holds Promise of Few or No Blood Clots, Other Adverse Effects

    Recent research has shown that a new combined oral contraceptive has high efficacy, cycle control, and safety, even among a diverse American population that included women with a body mass index of 35 kg/m2. The medication contains estetrol (a novel estrogen) and drospirenone.
  • Pandemic Stress, Burnout Contribute to Nursing Pipeline Shortage

    Stress, burnout, turnover, and retirement have contributed to obstacles in the student-to-nursing workforce pipeline. Nursing students and other healthcare professionals have experienced anxiety during the COVID-19 pandemic, research shows. This affected both nursing and medical students as well as nurses working in any healthcare settings.
  • Research Shows Reproductive Health Nurses Needed in 2020s

    The United States will soon need millions more nurses than are currently working in healthcare. But employers, including family planning centers and OB/GYN offices, likely will have a difficult time finding nurses. The American Nurses Association predicts more registered nurse jobs will be available through 2022 than any other profession. A half-million nurses are expected to retire by the end of 2022.
  • Predicting Coronary Artery Disease in Breast Cancer Patients

    The authors applied an automated algorithm to calculate an Agatston coronary artery calcium score from non-ECG-gated planning CT scans in breast cancer patients undergoing radiation therapy. This provided a graded risk calculation that could encourage preventive measures in patients at highest risk of a cardiovascular disease event.
  • FFR Fails to Show Benefit in Treatment of Nonculprit Lesions After STEMI

    In this study of patients presenting with ST-elevation myocardial infarction and multivessel disease, nonculprit vessel percutaneous coronary intervention (PCI) guided by fractional flow reserve failed to show benefit vs. angiography-guided PCI in terms of clinical events at one year.
  • Aspirin, Clopidogrel, or Both After Coronary Interventions?

    A recent study of patients who had undergone a percutaneous coronary intervention and were transitioning from dual antiplatelet therapy to monotherapy showed clopidogrel was superior to aspirin for preventing further major adverse events, including bleeding.
  • Age Drives Stroke Risk in Atrial Fibrillation

    Among patients with newly diagnosed atrial fibrillation age 66-74 years without other CHA2DS2-VASc risk factors for thromboembolism, the older they are in this age range, the more likely they are to experience a stroke.
  • Time of the Essence with Dapagliflozin for Heart Failure

    By adding dapagliflozin to maximally tolerated standard therapy for heart failure with reduced left ventricular ejection fraction, researchers noted the reduction in mortality and recurrent heart failure began within one month of starting this therapy.
  • Tracheostomy Emergencies

    Management of tracheostomy emergencies requires the use of specialized knowledge, resources, and equipment. Specific complications that the emergency physician should be familiar with are discussed.
  • Stimulant-Based Drugs of Abuse in the Trauma Patient

    Substance abuse is a major healthcare issue with effects on all aspects of patient care, including trauma. A large percentage of trauma patients have a positive drug screen, and acute and chronic abuse have impacts both on the acute and long-term management of these patients. This report is the first of a two-part series and focuses on stimulants and substances with sympathomimetic properties, with particular attention to the impact on the trauma patient.